On Sunday 13 January, the Australian Labor Party (ALP) announced that it is committed to the continued support of JDRF’s type 1 diabetes Clinical Research Network (CRN), if elected to power in the 2019 election. The ALP committed to $50m, over five years, to ensure the world-class research delivered by the CRN can be expanded upon and continue to deliver for Australians with type 1 diabetes.
The CRN plays an integral role in supporting world class Australian research into the cure, prevention and treatment of type 1 diabetes. The CRN is vital to all Australians with type 1 diabetes who will continue to have access to innovative clinical trials while researchers will be able to and work together with Australian and international colleagues to ensure that innovations and discoveries can be translated from the lab into safe, effective treatments.
Commenting on the announcement, head of research development at JDRF and the director of the CRN, Dr. Dorota Pawlak said “The CRN has the patient benefit as its primary goal and endeavours to bridge the gap between the discovery in the lab and translation to meaningful treatments. The continuation of the CRN will accelerate our progress into the causes of type 1, how we can treat it and hopefully stop it.
More than 120,000 Australians currently live with type 1 diabetes.
For more information on the announcement please visit JDRF